School program to prevent rheumatic heart disease
Part of Bones, joints & muscles, Heart & circulation, Infections, Skin clinical trials.
This study tests whether a program in schools can help prevent rheumatic heart disease in children. If your child is between 5 and 16 years old and attends a participating school, they may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 5 and 16 years old.
- Your child attends one of the selected schools.
- You and your child agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a prevention program done at a specific school can reduce how common “latent” (hidden) rheumatic heart disease is in children. If you attend the study’s school in Tulsipur, this program may be offered to help protect students’ heart health over time.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
This trial tests whether added support helps people stick to their prescribed antibiotics for rheumatic heart disease. It includes adults, children, guardians, community health workers, and healthcare workers.
This trial tests a vaccine called StreptInCor to see if it's safe and helps the body build immunity against strep bacteria. It may help prevent serious complications like rheumatic fever and heart damage.
This study tests whether a fun, educational program (with games and activities) can help students in Nepal learn more about rheumatic fever and rheumatic heart disease. If you are in grades 6–9 at a public school, you may be able to join and help see if this approach works.
This study looks at whether building a better, sustainable cardiac surgery service can reduce the burden of rheumatic heart disease. It focuses on patients who need cardiac surgery at a specific hospital during a training and research program.
Hear when a new Rheumatic Heart Disease in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.